C

Carisma Therapeutics, Inc. (CARM)

PNK – Real Time Price. Currency in USD

0.00

+0.00 (50.00%)

At close: May 12, 2026, 4:00 PM EDT

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Carisma Therapeutics, Inc. (CARM)

PNK – Real Time Price. Currency in USD

0.00

+0.00 (50.00%)

At close: May 12, 2026, 4:00 PM EDT

05.12.2025

Carisma Announces Delisting from Nasdaq and SEC Deregistration

PHILADELPHIA , Dec. 5, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (OTCID: CARM) (the "Company") today announced that its Board of Directors (the "Board") has approved and the Company intends to proceed with the voluntary delisting of its common stock from The Nasdaq Stock Market LLC ("Nasdaq") and the deregistration of its common stock in order to suspend and ultimately terminate the Company's reporting obligations under the Securities and Exchange Act of 1934, as amended (the "Exchange Act"). As previously reported, as a result of the Company's previously disclosed noncompliance with the bid price, market value of listed securities, and market value of publicly held shares requirements set forth in Nasdaq Listing Rules 5450(a)(1), 5450(b)(2)(C), and 5450(b)(2)(A), respectively, the Company received a delist determination letter from Nasdaq on October 9, 2025 (the "Determination Letter") and the Company's common stock was suspended from trading on Nasdaq effective at the open of business on October 13, 2025.

Videos

No Data

There is no data to display

Press releases

05.12.2025

Carisma Announces Delisting from Nasdaq and SEC Deregistration

PHILADELPHIA , Dec. 5, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (OTCID: CARM) (the "Company") today announced that its Board of Directors (the "Board") has approved and the Company intends to proceed with the voluntary delisting of its common stock from The Nasdaq Stock Market LLC ("Nasdaq") and the deregistration of its common stock in order to suspend and ultimately terminate the Company's reporting obligations under the Securities and Exchange Act of 1934, as amended (the "Exchange Act"). As previously reported, as a result of the Company's previously disclosed noncompliance with the bid price, market value of listed securities, and market value of publicly held shares requirements set forth in Nasdaq Listing Rules 5450(a)(1), 5450(b)(2)(C), and 5450(b)(2)(A), respectively, the Company received a delist determination letter from Nasdaq on October 9, 2025 (the "Determination Letter") and the Company's common stock was suspended from trading on Nasdaq effective at the open of business on October 13, 2025.

Search stocks

Carisma Therapeutics, Inc. (CARM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Carisma Therapeutics, Inc. (CARM)

Carisma Announces Delisting from Nasdaq and SEC Deregistration

Videos

No Data

Press releases

Carisma Announces Delisting from Nasdaq and SEC Deregistration